Tempest Therapeutics, Inc. Payments to Acquire Interest in Joint Venture
Tempest Therapeutics, Inc. (TPST) reported Payments to Acquire Interest in Joint Venture of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2018-11-09
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for the quarter ending 2017-12-31 was $550.00K.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for the quarter ending 2017-09-30 was $550.00K, a 45.00% decline year-over-year.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for the quarter ending 2017-06-30 was $0.00.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for fiscal 2017 was $1.10M, a 37.14% decline from fiscal 2016.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for fiscal 2016 was $1.75M, a 16.67% increase from fiscal 2015.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for fiscal 2015 was $1.50M, a 0.00% change from fiscal 2014.
- Tempest Therapeutics, Inc. payments to acquire interest in joint venture for fiscal 2014 was $1.50M.
| Period end | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month | Payments to Acquire Interest in Joint Venture 30 month | Payments to Acquire Interest in Joint Venture 33 month | Payments to Acquire Interest in Joint Venture 36 month |
|---|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | ||||||
| 2017-12-31 | $550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.10M derived: sum of 2 quarters · filed 2018-11-09 | $1.10M derived: sum of 3 quarters · filed 2018-11-09 | $1.10M 10-K · filed 2018-03-15 | |||
| 2017-09-30 | $550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $550.00K derived: sum of 2 quarters · filed 2018-11-09 | $550.00K 10-Q · filed 2018-11-09 | $550.00K derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $1.00M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $1.00M derived: sum of 3 quarters · filed 2018-03-15 | $1.00M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.00M derived: sum of 2 quarters · filed 2018-03-15 | $1.00M derived: sum of 3 quarters · filed 2018-03-15 | $1.75M 10-K · filed 2018-03-15 | |||
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.00M derived: sum of 2 quarters · filed 2017-11-02 | $1.75M 10-Q · filed 2017-11-02 | $1.75M derived: sum of 4 quarters · filed 2018-03-15 | $3.30M 10-Q · filed 2017-05-09 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $750.00K 10-Q · filed 2017-08-03 | $750.00K derived: sum of 3 quarters · filed 2018-03-15 | $750.00K derived: sum of 4 quarters · filed 2018-03-15 | $2.30M 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $750.00K 10-Q · filed 2017-05-09 | $750.00K derived: sum of 2 quarters · filed 2018-03-15 | $750.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.50M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $750.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.50M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $750.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.50M 10-Q · filed 2016-11-03 | $1.50M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.50M 10-Q · filed 2016-08-04 | $1.50M derived: sum of 3 quarters · filed 2017-03-02 | $1.50M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-03-31 | $750.00K 10-Q · filed 2016-05-05 | $750.00K derived: sum of 2 quarters · filed 2017-03-02 | $750.00K derived: sum of 3 quarters · filed 2017-03-02 | $750.00K derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $1.50M 10-K · filed 2017-03-02 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $1.50M 10-Q · filed 2015-11-05 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.50M 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | $1.50M 10-Q · filed 2015-05-11 | $1.50M 10-Q · filed 2014-05-08 | |||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |